Schedule 13G ownership disclosure
GRI BIO INC
Common stock, par value $0.0001 per share · CUSIP: 3622AW403
Event date: 2025-12-12
- Filing-level shares
- 1,197,755.00
- Percent of class
- 11.83%
- Lincoln Alternative Strategies LLC
Shares: 1,197,755.00 · Class: 11.83%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-029404
- Form type
- SCHEDULE 13G
- Filer
- GRI Bio, Inc.
- CIK
- CIK 1824293
- Filed
- Dec 29, 2025
- Reporting period
- Dec 12, 2025
- Description
- Schedule 13G beneficial ownership